| 45.95 Delayed Data As of Nov 20 |  -0.27 / -0.58%Today’s Change | 40.00 Today|||52-Week Range 47.47 | +5.85% Year-to-Date |
| 2 Biotech Stocks Fighting Alzheimer’s Disease to Own Now Nov 09 / MotleyFool.com - Paid Partner Content |
| Previous close | 46.22 |
| Today’s open | 46.07 |
| Day’s range | 45.67 - 46.21 |
| Volume | 869,263 |
| Average volume (3 months) | 1,427,843 |
| Market cap | $115.0B |
| Earnings growth (last year) | +19.94% |
| Earnings growth (this year) | +5.21% |
| Earnings growth (next 5 years) | +7.00% |
| Revenue growth (last year) | +2.83% |
| P/E ratio | 29.0 |
| Price/Sales | 2.68 |
| Price/Book | 1.71 |
| Today’s change | Today’s % change | |
|---|---|---|
| GSKGlaxoSmithKline | -0.58 | -1.30% |
| LLYEli Lilly and Co | -0.49 | -0.43% |
| AZNAstraZeneca | -0.66 | -1.38% |
| NVONovo Nordisk | -2.58 | -4.52% |
| Next reporting date | February 6, 2020 |
| EPS forecast (this quarter) | $0.70 |
| Annual revenue (last year) | $40.7B |
| Annual profit (last year) | $5.1B |
| Net profit margin | 12.53% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
